Genome-wide homozygosity signature and risk of Hodgkin lymphoma

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Sud, Amit ^a   Cooke, Rosie ^a   Swerdlow, Anthony J ^a   Houlston, Richard S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; GENE FREQUENCY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEALTH SURVEY; HODGKIN DISEASE; HOMOZYGOTE; HUMAN; RECESSIVE GENE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

CASE-CONTROL STUDIES; GENE FREQUENCY; GENES, RECESSIVE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HODGKIN DISEASE; HOMOZYGOTE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RISK; UNITED KINGDOM;

EID: 84942333270     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14315     Document Type: Article

References (45)

1. Smith, A. et al. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK/s Haematological Malignancy Research Network. Br J Cancer 112, 1575-1584 (2015).
2. Swerdlow, S. H. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (IARC Press, Lyon, France, 2008).
3. Goldin, L. R. et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100, 1902-8 (2004).
4. Enciso-Mora, V. et al. A genome-wide association study of Hodgkins lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet 42, 1126-30 (2010).
5. Moutsianas, L. et al. Multiple Hodgkin lymphoma-associated loci within the HLA region at chromosome 6p21.3. Blood 118, 670-4 (2011).
6. Cozen, W. et al. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood 119, 469-75 (2012).
7. Urayama, K. Y. et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 104, 240-53 (2012).
8. Frampton, M. et al. Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkins lymphoma. Nat Commun 4, 2549 (2013).
9. Cozen, W. et al. A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. Nat Commun 5, 3856 (2014).
10. Ball, R. D. Experimental designs for robust detection of effects in genome-wide case-control studies. Genetics 189, 1497-514 (2011).
11. Bener, A. et al. Impact of consanguinity on cancer in a highly endogamous population. Asian Pac J Cancer Prev 10, 35-40 (2009).
12. Feldman, J. G., Lee, S. L. and Seligman, B. Occurrence of acute leukemia in females in a genetically isolated population. Cancer 38, 2548-50 (1976).
13. Abramson, J. H. et al. Clustering of Hodgkins disease in Israel: a case-control study. Int J Epidemiol 9, 137-44 (1980).
14. Lebel, R. R. and Gallagher, W. B. Wisconsin consanguinity studies. II: Familial adenocarcinomatosis. Am J Med Genet 33, 1-6 (1989).
15. Shami, S. A., Qaisar, R. and Bittles, A. H. Consanguinity and adult morbidity in Pakistan. Lancet 338, 954 (1991).
16. Simpson, J. L., Martin, A. O., Elias, S., Sarto, G. E. and Dunn, J. K. Cancers of the breast and female genital system: search for recessive genetic factors through analysis of human isolate. Am J Obstet Gynecol 141, 629-36 (1981).
17. Demant, P. Cancer susceptibility in the mouse: genetics, biology and implications for human cancer. Nat Rev Genet 4, 721-34 (2003).
18. Henry, I. et al. Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351, 665-7 (1991).
19. Lencz, T. et al. Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. Proc Natl Acad Sci USA 104, 19942-7 (2007).
20. Yang, H. C., Chang, L. C., Liang, Y. J., Lin, C. H. and Wang, P. L. A genome-wide homozygosity association study identifies runs of homozygosity associated with rheumatoid arthritis in the human major histocompatibility complex. PLoS One 7, e34840 (2012).
21. Simon-Sanchez, J. et al. Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinsons disease. PLoS One 7, e28787 (2012).
22. Power, C. and Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 35, 34-41 (2006).
23. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-75 (2007).
24. Voight, B. F., Kudaravalli, S., Wen, X. and Pritchard, J. K. A map of recent positive selection in the human genome. PLoS Biol 4, e72 (2006).
25. Tajima, F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123, 585-95 (1989).
26. Holsinger, K. E. and Weir, B. S. Genetics in geographically structured populations: defining, estimating and interpreting F(ST). Nat Rev Genet 10, 639-50 (2009).
27. Li, M. J. et al. dbPSHP: a database of recent positive selection across human populations. Nucleic Acids Res 42, D910-6 (2014).
28. Wang, E. T., Kodama, G., Baldi, P. and Moyzis, R. K. Global landscape of recent inferred Darwinian selection for Homo sapiens. Proc Natl Acad Sci USA 103, 135-40 (2006).
29. Williamson, S. H. et al. Localizing recent adaptive evolution in the human genome. PLoS Genet 3, e90 (2007).
30. The International HapMap, C. A haplotype map of the human genome. Nature 437, 1299-1320 (2005).
31. Craddock, N. et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464, 713-20 (2010).
32. Aggarwal, B. B. Nuclear factor-κ B: The enemy within. Cancer Cell 6, 203-208 (2004).
33. Bernal-Mizrachi, L., Lovly, C. M. and Ratner, L. The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. Proc Natl Acad Sci USA 103, 9220-5 (2006).
34. Liu, X. et al. Mutations of NFKBIA in biopsy specimens from Hodgkin lymphoma. Cancer Genet Cytogenet 197, 152-7 (2010).
35. Oeckinghaus, A. and Ghosh, S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1, a000034 (2009).
36. Assie, G., LaFramboise, T., Platzer, P. and Eng, C. Frequency of germline genomic homozygosity associated with cancer cases. Jama 299, 1437-45 (2008).
37. Bacolod, M. D. et al. The signatures of autozygosity among patients with colorectal cancer. Cancer Res 68, 2610-21 (2008).
38. Gibson, J., Morton, N. E. and Collins, A. Extended tracts of homozygosity in outbred human populations. Hum Mol Genet 15, 789-95 (2006).
39. Simon-Sanchez, J. et al. Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals. Hum Mol Genet 16, 1-14 (2007).
40. Li, L. H. et al. Long contiguous stretches of homozygosity in the human genome. Hum Mutat 27, 1115-21 (2006).
41. Broman, K. W. and Weber, J. L. Long homozygous chromosomal segments in reference families from the centre dEtude du polymorphisme humain. Am J Hum Genet 65, 1493-500 (1999).
42. Woods, C. G. et al. Quantification of homozygosity in consanguineous individuals with autosomal recessive disease. Am J Hum Genet 78, 889-96 (2006).
43. Hosking, F. J. et al. Genome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk. Blood 115, 4472-7 (2010).
44. Spain, S. L., Cazier, J. B., Houlston, R., Carvajal-Carmona, L. and Tomlinson, I. Colorectal cancer risk is not associated with increased levels of homozygosity in a population from the United Kingdom. Cancer Res 69, 7422-9 (2009).
45. Enciso-Mora, V., Hosking, F. J. and Houlston, R. S. Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations. Eur J Hum Genet 18, 909-14 (2010).